Psychedelic stocks are quickly emerging as a red-hot sector.
Need evidence? Take a look at Mind Medicine (NASDAQ: MNMD), a promising young biotech headquartered in New York, New York, that specializes in developing psychedelic drug therapies.
Shares were just uplisted from over-the-counter (OTC) markets to the NASDAQ stock exchange, and this stock is now up more than 1,000% in the last nine months.
If you want to invest in the psychedelic therapies industry and you missed the Mind Med trade, don’t worry. I see this same pattern unfolding once again. I’ll share the name of that company in this week’s newsletter.
About Cannabis Stock Trades
Legal Cannabis is the fastest growing industry in North America. While this is creating a huge opportunity, it is also creating a problem. It is difficult for investors to find reliable information on the cannabis industry and the small group of hidden companies cashing in on this explosive trend. Cannabis Stock Trades solves this problem.
Michael Vodicka Cannabis Stock Trader
Michael Vodicka is a globally syndicated equity analyst with more than 20 years of experience in trading and investing. His research has been featured in some of the industry’s most respected publications. He has been investing and leading investors in the cannabis sector since 2013.